TimeScale Financial’s Insmed INSM Stock Holding History

TimeScale Financial’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15	Closed	–	–	525
2019 Q3	$0	Hold	15	–	–	﹤0.01%	520
2019 Q2	$0	Buy	+15	New	+$418	﹤0.01%	519

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TimeScale Financial's INSM Position: Q4 2019 in Review

TimeScale Financial sold out of Insmed (INSM) in Q4 2019, closing a stake of 15 shares.

TimeScale Financial first reported a position in INSM in Q2 2019 and held it in 2 quarters. The position peaked at $0 in Q3 2019. 176 funds tracked by Wall St. Rank hold INSM as of Q4 2019.

TimeScale Financial reported no remaining Insmed position as of Q4 2019 after selling out during the quarter.
TimeScale Financial sold 15 Insmed shares in Q4 2019.
TimeScale Financial first reported a position in Insmed in Q2 2019 and held it in 2 quarters.
TimeScale Financial's Insmed position peaked at $0 in Q3 2019.
176 funds tracked by Wall St. Rank held Insmed as of Q4 2019.

Based on TimeScale Financial's 13F filing for Q4 2019, filed 28 Jan 2020.